Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) announced its sponsorship and participation in the 19th Annual International Symposium on Ventricular Arrhythmias, scheduled for October 11-12, 2024, in New York. The company's Ultra-Low Temperature Cryoablation (ULTC) technology will be featured in the symposium's scientific program.
Two presentations are highlighted:
- Dr. Atul Verma will present Cryocure-VT: One-year Results and Next Steps (FULCRUM-VT) on October 11 at 4:40 p.m. ET
- Professor Dr. Roland Tilz will present a recorded case on PVC Ablation using Ultra-low Cryoablation on October 12 at 12:35 p.m. ET
Olav Bergheim, President and CEO of Adagio, expressed pride in supporting the event and anticipation for discussing their technology and clinical program with experts in the field.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ha annunciato il suo sponsorizzazione e partecipazione al 19° Simposio Internazionale annuale sulle aritmie ventricolari, previsto per l'11-12 ottobre 2024 a New York. La tecnologia di criobrazione a ultra-bassa temperatura (ULTC) dell'azienda sarà presentata nel programma scientifico del simposio.
Due presentazioni sono in evidenza:
- Il Dr. Atul Verma presenterà Cryocure-VT: Risultati a un anno e Prossimi Passi (FULCRUM-VT) l'11 ottobre alle 16:40 ET
- Il Professor Dr. Roland Tilz presenterà un caso registrato sulla ablazione dei PVC utilizzando la criobrazione ultra-bassa il 12 ottobre alle 12:35 ET
Olav Bergheim, Presidente e CEO di Adagio, ha espresso orgoglio nel supportare l'evento e attesa per discutere della loro tecnologia e programma clinico con esperti del settore.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) anunció su patrocinio y participación en el 19º Simposio Internacional Anual sobre Arritmias Ventriculares, programado para el 11-12 de octubre de 2024, en Nueva York. La tecnología de crioblation a ultra baja temperatura (ULTC) de la empresa será presentada en el programa científico del simposio.
Se destacan dos presentaciones:
- El Dr. Atul Verma presentará Cryocure-VT: Resultados de un año y Próximos Pasos (FULCRUM-VT) el 11 de octubre a las 16:40 ET
- El Profesor Dr. Roland Tilz presentará un caso grabado sobre la ablación de PVC utilizando crioblation a ultra baja temperatura el 12 de octubre a las 12:35 ET
Olav Bergheim, Presidente y CEO de Adagio, expresó su orgullo por apoyar el evento y anticipación por discutir su tecnología y programa clínico con expertos en el campo.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM)는 2024년 10월 11-12일 뉴욕에서 열리는 제19회 국제 심장부정맥 심포지엄에서 후원 및 참여를 발표했습니다. 회사의 초저온 냉동 절제 기술 (ULTC)가 심포지엄의 과학 프로그램에 소개될 예정입니다.
강조되는 두 개의 발표:
- Atul Verma 박사가 Cryocure-VT: 1년 결과 및 다음 단계(FULCRUM-VT)를 10월 11일 오후 4:40 ET에 발표합니다.
- Roland Tilz 교수님이 초저온 냉동 절제를 이용한 PVC 절제의 녹화된 사례를 10월 12일 오후 12:35 ET에 발표합니다.
Adagio의 대통령 겸 CEO인 Olav Bergheim은 이 행사를 지원하게 되어 자랑스럽다고 전하며, 해당 분야의 전문가들과 기술 및 임상 프로그램에 대해 논의할 날을 기대하고 있습니다.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) a annoncé son sponsoring et participation au 19ème Symposium international annuel sur les arythmies ventriculaires, prévu les 11 et 12 octobre 2024 à New York. La technologie de cryoablation à ultra-basse température (ULTC) de l'entreprise sera mise en avant dans le programme scientifique du symposium.
Deux présentations sont mises en avant :
- Le Dr Atul Verma présentera Cryocure-VT: Résultats d'un an et étapes suivantes (FULCRUM-VT) le 11 octobre à 16h40 ET
- Le Professeur Dr Roland Tilz présentera un cas enregistré sur l'ablath mention des PVC utilisant la cryoablation ultra-basse le 12 octobre à 12h35 ET
Olav Bergheim, Président et CEO d'Adagio, a exprimé sa fierté de soutenir l'événement et son impatience de discuter de sa technologie et de son programme clinique avec des experts dans le domaine.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) gab seine Sponsoring und Teilnahme am 19. Internationalen Symposium für Ventrikuläre Arrhythmien bekannt, das für den 11.-12. Oktober 2024 in New York geplant ist. Die Ultra-Niedertemperatur-Kryoablation (ULTC) Technologie des Unternehmens wird im wissenschaftlichen Programm des Symposiums vorgestellt.
Zwei Präsentationen werden hervorgehoben:
- Dr. Atul Verma wird am 11. Oktober um 16:40 Uhr ET Cryocure-VT: Ein-Jahres Ergebnisse und nächste Schritte (FULCRUM-VT) präsentieren.
- Prof. Dr. Roland Tilz wird am 12. Oktober um 12:35 Uhr ET einen aufgezeichneten Fall zur PVC-Ablation mit Ultra-Niedertemperatur-Kryoablation präsentieren.
Olav Bergheim, Präsident und CEO von Adagio, äußerte Stolz auf die Unterstützung der Veranstaltung und Vorfreude darauf, ihre Technologie und klinisches Programm mit Experten auf diesem Gebiet zu diskutieren.
- Participation in a major industry symposium, potentially increasing visibility and networking opportunities
- Presentation of clinical results and technology applications at the symposium, showcasing the company's innovations
- None.
In addition to participating in the commercial exhibition, Adagio’s proprietary Ultra-Low Temperature Cryoablation (ULTC) technology will be featured within the scientific program of the Symposium.
Presentation Details:
Date: October 11, 2024
Time: 4:40 p.m. ET
Topic: Cryocure-VT: One-year Results and Next Steps (FULCRUM-VT)
Presenter: Dr. Atul Verma, Director, Division of Cardiology at McGill University Health Centre and FULCRUM-VT Co-Principal Investigator
Date: October 12, 2024
Time: 12:35 p.m. ET
Topic: PVC Ablation using Ultra-low Cryoablation (Recorded Case)
Presenter: Professor Dr. Roland Tilz, Director of the Department of Rhythmology at the University Clinic Schleswig-Holstein
“The annual VT Symposium is a seminal scientific and educational event for everyone involved and interested in the treatment of ventricular arrhythmias,” said Olav Bergheim, President and CEO of Adagio. “We are proud to be a continuing supporter and look forward to discussing our technology and clinical program with the top experts in the field.”
About Adagio Medical
Adagio Medical is an early commercial stage medical device company located in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241007783534/en/
Media Contact
Ilya Grigorov
Vice President, Global Marketing and Product Management of Adagio Medical, Inc.
igrigorov@adagiomedical.com
Investor Contact
IR@adagiomedical.com
Source: Adagio Medical Holdings, Inc.
FAQ
When and where is Adagio Medical (ADGM) participating in the Ventricular Arrhythmias Symposium?
What technology will Adagio Medical (ADGM) feature at the Ventricular Arrhythmias Symposium?
Who will present the Cryocure-VT results for Adagio Medical (ADGM) at the symposium?
What is the topic of Professor Dr. Roland Tilz's presentation for Adagio Medical (ADGM)?
